• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Large owner Allied Physicians Of California, A Professional Medical Corp returned $10,551,000 worth of shares to the company (300,000 units at $35.17) (SEC Form 4)

    1/22/25 7:46:11 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary
    Get the next $ASTH alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp

    (Last) (First) (Middle)
    C/O ASTRANA HEALTH, INC.
    1668 S. GARFIELD AVE., 2ND FLOOR

    (Street)
    ALHAMBRA CA 91801

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Astrana Health, Inc. [ ASTH ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    01/17/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 01/17/2025 D(2) 300,000 D $35.17 6,832,698 D(1)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp

    (Last) (First) (Middle)
    C/O ASTRANA HEALTH, INC.
    1668 S. GARFIELD AVE., 2ND FLOOR

    (Street)
    ALHAMBRA CA 91801

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    Director X 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Lam Thomas S.

    (Last) (First) (Middle)
    C/O ASTRANA HEALTH, INC.
    1668 S. GARFIELD AVE., 2ND FLOOR

    (Street)
    ALHAMBRA CA 91801

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    1. Name and Address of Reporting Person*
    Sim Kenneth T.

    (Last) (First) (Middle)
    C/O ASTRANA HEALTH, INC.
    1668 S. GARFIELD AVE., 2ND FLOOR

    (Street)
    ALHAMBRA CA 91801

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director 10% Owner
    X Officer (give title below) Other (specify below)
    Executive Chairman
    Explanation of Responses:
    1. Allied Physicians of California, a Professional Medical Corporation ("APC"), is a consolidated affiliate of the issuer of which Dr. Kenneth Sim, the issuer's Executive Chairman of the Board of Directors, is Chairman and a director and stockholder, and Dr. Thomas Lam, the issuer's Vice Chairman of the Board of Directors, is the Chief Executive Officer and Chief Financial Officer and a director and stockholder. Each of Dr. Sim and Dr. Lam disclaims beneficial ownership of the securities held by APC except to the extent of his pecuniary interest therein. Each of Dr. Sim and Dr. Lam holds, directly and/or indirectly, additional securities of the issuer.
    2. On January 17, 2025, the issuer entered into a stock repurchase agreement with APC, pursuant to which the issuer agreed to repurchase 300,000 shares of the issuer's common stock from APC. The agreement closed, and the issuer completed the stock repurchase, on the same day. The issuer's Board of Directors and the Audit Committee of the Board of Directors approved the repurchase.
    ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL CORPORATION, /s/ Thomas S. Lam, Chief Executive Officer and Chief Financial Officer 01/22/2025
    /s/ Thomas S. Lam 01/22/2025
    /s/ Kenneth T. Sim 01/22/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $ASTH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ASTH

    DatePrice TargetRatingAnalyst
    4/1/2025$36.00Equal Weight
    Barclays
    10/14/2024$66.00Buy
    TD Cowen
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    7/11/2024$44.00 → $50.00Hold → Buy
    Truist
    5/30/2024$54.00Outperform
    Robert W. Baird
    More analyst ratings

    $ASTH
    SEC Filings

    See more
    • Astrana Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      7/2/25 7:05:47 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • SEC Form S-8 filed by Astrana Health Inc.

      S-8 - Astrana Health, Inc. (0001083446) (Filer)

      6/13/25 5:22:20 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      6/11/25 4:15:29 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Astrana Health Announces Closing of Prospect Health Acquisition

      ALHAMBRA, Calif., July 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced it closed the acquisition of Prospect Health on July 1st, 2025. Prospect Health is a value-based, integrated care delivery network which coordinates the delivery of high-quality care for all. With a network of over 11,000 providers across Southern Cali

      7/2/25 7:00:00 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health Strengthens Leadership Team to Scale AI-Enabled Healthcare Delivery Platform for All

      ALHAMBRA, Calif., June 3, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced several key additions to its senior leadership team. These appointments reinforce the company's commitment to scaling its AI-enabled, value-based care platform and driving growth across its expanding national footprint. Sherry McBride has joined Astran

      6/3/25 8:00:00 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. to Participate in Upcoming Investor Conference

      ALHAMBRA, Calif., June 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO is participating in the William Blair 2025 Growth Stock Conference, being held in Chicago, from Tuesday, June 3, 2025 to Thursday June 5, 2025 including a presentation at 10:40 am CT on Wednesday, June 4. The we

      6/2/25 4:56:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on Astrana Health with a new price target

      Barclays initiated coverage of Astrana Health with a rating of Equal Weight and set a new price target of $36.00

      4/1/25 7:41:49 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • TD Cowen initiated coverage on Astrana Health with a new price target

      TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00

      10/14/24 7:24:49 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • KeyBanc Capital Markets initiated coverage on Astrana Health

      KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight

      10/11/24 7:36:28 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Medical Officer Kumar Dinesh M. covered exercise/tax liability with 6,831 shares, decreasing direct ownership by 3% to 218,811 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      7/2/25 6:24:26 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Director Mazdyasni Matthew was granted 6,449 shares, increasing direct ownership by 78% to 14,763 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      6/13/25 4:21:38 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Director Marsh Linda was granted 6,449 shares, increasing direct ownership by 8% to 83,641 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      6/13/25 4:20:39 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Financials

    Live finance-specific insights

    See more
    • Astrana Health, Inc. Reports First Quarter 2025 Results

      Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025. "Astrana's strong start to the year reflects the continued momentum behind our mis

      5/8/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Schedules 2025 First Quarter Financial Results Release and Conference Call

      ALHAMBRA, Calif., April 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2025, after the close of the stock market on Thursday, May 8, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      4/15/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results

      Company to Host Conference Call on Thursday, February 27, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Feb. 27, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2024. "Astrana Health's strong performance in 2024 highlights the s

      2/27/25 4:27:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary